Douglas C. Lane & Associates’s AbbVie ABBV Stock Holding History

Douglas C. Lane & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.35M	Sell	22,757 -1,818	-7%	-$105K	0.04%	146
2015 Q3	$1.34M	Sell	24,575 -1,207	-5%	-$78.6K	0.04%	144
2015 Q2	$1.73M	Buy	25,782 +944	+4%	+$61.6K	0.05%	142
2015 Q1	$1.45M	Sell	24,838 -1,430	-5%	-$86.4K	0.04%	137
2014 Q4	$1.72M	Sell	26,268 -19,925	-43%	-$1.26M	0.05%	134
2014 Q3	$2.67M	Sell	46,193 -320,239	-87%	-$17.8M	0.08%	126
2014 Q2	$20.7M	Sell	366,432 -58,708	-14%	-$3.08M	0.63%	68
2014 Q1	$21.9M	Sell	425,140 -8,571	-2%	-$433K	0.7%	60
2013 Q4	$22.9M	Sell	433,711 -7,898	-2%	-$388K	0.76%	58
2013 Q3	$19.8M	Sell	441,609 -12,661	-3%	-$561K	0.72%	61
2013 Q2	$18.8M	Buy	+454,270	New	+$19.9M	0.73%	60

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Douglas C. Lane & Associates's ABBV Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its AbbVie (ABBV) stake by 7.4% in Q4 2015, selling an estimated $105K and leaving 22,757 shares worth $1.35M. The position accounts for 0.04% of the portfolio, ranked #146.

Douglas C. Lane & Associates first reported a position in ABBV in Q2 2013 and has held it in 11 quarters since. The position peaked at $22.9M in Q4 2013. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Douglas C. Lane & Associates held 22,757 shares of AbbVie worth $1.35M as of Q4 2015.
Douglas C. Lane & Associates sold 1,818 AbbVie shares in Q4 2015, an estimated $105K.
AbbVie made up 0.04% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #146 holding.
Douglas C. Lane & Associates first reported a position in AbbVie in Q2 2013 and has held it in 11 quarters since.
Douglas C. Lane & Associates's AbbVie position peaked at $22.9M in Q4 2013.
1,636 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.